Four things to know:
1. VUMC reported operating revenues of $2.17 billion in the six months ended Dec. 21, up from $2.01 billion in the same period a year earlier. The boost was largely attributable to higher net patient service revenue, which climbed 8 percent year over year.
2. VUMC’s operating expenses increased 6 percent year over year to $2.1 billion in the six months ended Dec. 31.
3. VUMC ended the six-month period with operating income of $73.89 million, up from $30.63 million in the six months ended Dec. 31, 2018.
4. “Our YTD FY19 operating results reflect our focus on increases [in] net patient service revenue while continuing to tightly manage our variable and fixed costs, which is evidenced by the fact that expenses grew at a rate of 6 percent while revenue and net patient revenue grew at 8 percent,” VUMC said in the financial documents. “In addition to the significantly improved operating performance, the balance sheet has improved year over year.”
More articles on healthcare finance:
New York health system cuts jobs after poor financial performance
Bankruptcy court approves $610M bid for 4 California hospitals
Why 2 hospitals are slashing medical bills by 50%
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
